Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
5 results
  • Gastric (Stomach) Cancer

17-489          Phase I

A Phase 1 Open-label Dose Escalation and Dose Expansion Study of CGX1321 in Subjects with Advanced Solid Tumors and Phase 1b Study of CGX1321 in Combination with Pembrolizumab in Subjects with Advanced Gastrointestinal Tumors (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer, Lung Cancer, Head and Neck Cancer, Lymphoma

17-674          Phase I

A Phase 1, Dose Escalation Study of ALX148 in Patients With Advanced Solid Tumors and Lymphoma (View details on clinicaltrial.gov)

  • Lung Cancer, Gastric (Stomach) Cancer, Pancreatic Cancer

16-450          Phase II

A Phase 1/2a, open-label multicenter study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of PEN-221 in patients with somatostatin receptor 2 expressing advanced cancers, including gastroenteropancreatic or lung or thymus or other neuroendocrine tumors or small cell lung cancer or large cell neuroendocrine carcinoma of the lung. (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer, Pancreatic Cancer, Colorectal Cancer

17-137          Phase I

A Phase I Dose Escalation Study, with Cohort Expansion, to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of AbGn-107 Therapy in Patients with Chemo-refractory Locally Advanced, Recurrent, or Metastatic Gastric, Colorectal, or Pancreatic Cancer. (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer

18-224          Phase I

An Open-Label, Dose Escalation, Phase 1, First-in-Human Study of TAK-164, an Antibody-Drug Conjugate, in Patients with Advanced Gastrointestinal Cancers Expressing Guanylyl Cyclase C (View details on clinicaltrial.gov)

Showing 1 - 10 of 5 results